N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway

A compound which is:

A method of treating a condition in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the compound:

• or a pharmaceutically acceptable salt thereof;
• wherein the condition is selected from the group consisting of cancer, sarcoma, melanoma, skin cancer, haematological tumors, lymphoma, carcinoma, leukemia, skin fibrosis, idiopathic pulmonary fibrosis, renal interstitial fibrosis, liver fibrosis, proteinuria, kidney graft rejection, osteoarthritis, Parkinson's disease, cystoid macular edema, uveitis associated cystoid macular edema, retinopathy, diabetic retinopathy, and retinopathy of prematurity.

A method of treating a condition in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the compound:

• wherein the condition is selected from the group consisting of cancer, sarcoma, melanoma, skin cancer, haematological tumors, lymphoma, carcinoma, leukemia, skin fibrosis, idiopathic pulmonary fibrosis, renal interstitial fibrosis, liver fibrosis, proteinuria, kidney graft rejection, osteoarthritis, Parkinson's disease, cystoid macular edema, uveitis associated cystoid macular edema, retinopathy, diabetic retinopathy, and retinopathy of prematurity.